Zhijie Wang, Jia Zhong, Jianchun Duan, Jie Zhao, Zhehai Wang, Minglei Zhuo, Chengzhi Zhou, Zhenbin Li, Xiangjun Yi, Jianhua Chang, Shi Jin, Di Wu, Qibin Song, Xiaorong Dong, Lixia Ma, Bo Jin, Dongqing Lv, Zhe Liu, Lifeng Wang, Jie Wang. "Osimertinib with/without chemotherapy in patients with persistent ctDNA EGFR mutant (EGFRm) NSCLC at 3 weeks after 1L osimertinib: A randomized phase II study (FLAME study).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.17_suppl.lba101